Side effects related to cancer treatment - Case 1. Hepatitis following treatment with gefitinib

被引：32

作者：

Ho, C ^{[1
]}

Davis, J

Anderson, F

Bebb, G

Murray, N

机构：

[1] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada

[2] Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada

[3] Vancouver Gen Hosp, Dept Gastroenterol, Vancouver, BC V5Z 1M9, Canada

[4] Tom Baker Canc Clin, Dept Med Oncol, Calgary, AB, Canada

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 33期

关键词：

D O I：

10.1200/JCO.2004.00.6650

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：8531 / 8533

页数：3

共 3 条

[1] Severe acute interstitial pneumonia and gefitinib [J].

Inoue, A ;

Saijo, Y ;

Maemondo, M ;

Gomi, K ;

Tokue, Y ;

Kimura, Y ;

Ebina, M ;

Kikuchi, T ;

Moriya, T ;

Nukiwa, T .

LANCET, 2003, 361 (9352) :137-139

[2] Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - A randomized trial [J].

Kris, MG ;

Natale, RB ;

Herbst, RS ;

Lynch, TJ ;

Prager, D ;

Belani, CP ;

Schiller, JH ;

Kelly, K ;

Spiridonidis, H ;

Sandler, A ;

Albain, KS ;

Cella, D ;

Wolf, MK ;

Averbuch, SD ;

Ochs, JJ ;

Kay, AC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (16) :2149-2158

[3] Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer [J].

Miller, VA ;

Kris, WG ;

Shah, N ;

Patel, J ;

Azzoli, C ;

Gomez, J ;

Krug, LM ;

Pao, W ;

Rizvi, N ;

Pizzo, B ;

Tyson, L ;

Venkatraman, E ;

Ben-Porar, L ;

Memoli, N ;

Zakowski, M ;

Rusch, V ;

Heelan, RT .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1103-1109

← 1 →